Christina A. Sheil, MD, explains why polypharmacy has become one of the most significant challenges in modern healthcare.

There is new evidence suggesting therapy may lead to higher recovery rates than medication in people over 60 who experience anxiety disorders, says Associate Professor Carly Johnco. Anxiety disorders ...

If you have more than one chronic medical condition that you take medication for, your Part D plan or bundled plan provider may automatically enroll you for medication therapy management. If you live ...

Cancer, a complex and multifactorial disease, presents a significant challenge to global health. Despite significant advances in surgical, radiotherapeutic and immunological approaches, which have ...

Thyroid disorder patients are likely to have a prescription for various categories of drugs including those with a narrow therapeutic index and others, which affects thyroid function. However, ...

On Friday, the fledgling field of psychedelic medicine suffered a major setback. The FDA declined to approve MDMA-assisted therapy for PTSD, instead asking the drugmaker Lykos Therapeutics to conduct ...

Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.

Science and Practice suggests that while antidepressants and short-term psychodynamic therapy both help alleviate depression, medication might offer a slight advantage for individuals starting with ...